[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368268-105":59,"doc-detail-368268-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pancreatic-mixed-acinar-neuroendocrine-carcinoma-in-a-patient-with-a-germline-pten-variant-a-case-report-and-genomic-literature-review","Pancreatic Mixed Acinar-neuroendocrine Carcinoma in a Patient With a Germline PTEN Variant - A Case Report and Genomic Literature Review","","Rare pancreatic cancer can occur in Cowden syndrome (CS)/PTEN hamartoma tumor syndrome (PHTS), a hereditary disorder caused by germline PTEN variants. A late-40s man presented with pancreatic cancer and hepatic metastases; liver biopsy showed mixed acinar–neuroendocrine carcinoma. Genome profiling identified a germline PTEN variant (V201fs*1) and pathogenic GNAS and TP53 variants, supporting CS. Notably, KRAS mutations were absent, and the patient showed extreme resistance to multiple chemotherapy regimens. The case supports molecular and histologic distinctiveness and highlights the need for further PTEN-associated research and targeted strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pancreatic-mixed-acinar-neuroendocrine-carcinoma-in-a-patient-with-a-germline-pten-variant-a-case-report-and-genomic-literature-review/368268/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pancreatic-mixed-acinar-neuroendocrine-carcinoma-in-a-patient-with-a-germline-pten-variant-a-case-report-and-genomic-literature-review/368268.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What hereditary condition is highlighted in this case report, and what gene causes it?","Question",{"text":112,"@type":113},"The report focuses on Cowden syndrome (CS)/PTEN hamartoma tumor syndrome (PHTS), caused by germline pathogenic variants in the PTEN gene.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What diagnosis was determined from the patient’s biopsy and genomic profiling?",{"text":117,"@type":113},"Liver biopsy indicated mixed acinar–endocrine carcinoma, and cancer genome profiling identified a germline PTEN variant (V201fs*1) along with pathogenic GNAS and TP53 variants, supporting a diagnosis of CS.",{"name":119,"@type":110,"acceptedAnswer":120},"Which common pancreatic cancer alteration was absent, and how did the patient respond to treatment?",{"text":121,"@type":113},"KRAS mutations were absent. The patient showed extreme resistance to multiple chemotherapy regimens, including FOLFIRINOX and gemcitabine plus nab-paclitaxel, leading to rapid clinical decline.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368268,1790294977,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","doi: 10.21873/invivo.13921  \nPancreatic Mixed Acinar‐neuroendocrine Carcinoma in a Patient With a Germline PTEN Variant:  \nA Case Report and Genomic Literature Review  \nYOSUKE SAITO1, SHUHEI SUZUKI1,2, TOMOMI SANOMACHI3, KAHO KATO4,5, HIROYA OTAKE6, YUKO NISHISE7,  \nYUTA YAMADA1, KOKI SAITO8, KOSHI TAKAHASHI1, RYOSUKE KUMANISHI1, TADAHISA FUKUI1 and TAKASHI YOSHIOKA1 1 Department of Clinical Oncology, Yamagata University Hospital, Yamagata, Japan;  \n2Yamagata Hereditary Tumor Research Center, Yamagata University, Yamagata, Japan;  \n3 Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan;  \n4 Master of Public Health, Human Genetics, University of Pittsburgh, Pittsburgh, PA, U.S.A.;  \n5 Nihonkai General Hospital, Yamagata, Japan;  \nDepartments of 6 Pathology and 7Gastroenterology, Yamagata City Hospital Saiseikan, Yamagata, Japan; 8Tokyo Medical University, Tokyo, Japan  \nAbstract  \nBackground/Aim: Cowden syndrome (CS)/PTENhamartoma tumor syndrome (PHTS) is ahereditary disorder caused by germline PTEN variants. While patients with CS/PHTS have increased risk of various cancers, pancreatic cancer isnot typically associated with this syndrome. We reporta rare case of pancreatic mixed acinar‑neuroendocrine carcinoma in a patient with a germline PTEN variant, aiming to understand its molecular characteristics and clinical implications. Case Report: A male in his late 40s presented with pancreatic cancer and hepatic metastases. His medical history included thyroid cancer and familial gastrointestinal malignancies. Liver biopsy revealed mixed acinar‑endocrine carcinoma. Cancer genome profiling identified pathogenic variants in GNAS and TP53, along with a germline PTEN variant (V201fs*1), leading to a diagnosis of CS. Notably, KRAS mutations, commonly found in pancreatic cancer, were absent. The patient showed extreme resistance to multiple chemotherapy regimens, including FOLFIRINOX, gemcitabine plus nab‑paclitaxel, and cisplatin plus etoposide, resulting in rapid clinical decline.  \nConclusion: This case highlights a rare presentation of pancreatic cancer in CS/PHTS with distinct molecular and histological features. The absence ofKRAS mutation and presence of germline PTEN variant may have contributed to the aggressive clinical course and treatment resistance. These findings underscore the need for further research into the molecular mechanisms of PTEN‑associated pancreatic cancers and the development of targeted therapeutic strategies.  \nKeywords: Cowden syndrome, PTEN, pancreatic cancer, germline variant, genome profiling testing.  \n✉  \nShuhei Suzuki, Yamagata Hereditary Tumor Research Center, Yamagata University, 9908560 Yamagata, Japan. Tel: +81  \n236284006, e‑mail: s‑[suzuki@med.id.yamagata](suzuki@med.id.yamagata)‑[u.ac.jp](u.ac.jp)  \nReceived December 27, 2024 | Revised January 8, 2025 | Accepted January 9, 2025  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2025 The Author(s) . Anticancer Research is published by the International Institute of Anticancer Research.  \nIntroduction  \nCowden syndrome (CS)/PTEN hamartoma tumor syndrome (PHTS) is a hereditary disorder characterized by autosomal dominant inheritance, caused by germline pathogenic variants in phosphatase and tensin homolog (PTEN) gene (1) . Many CS/PHTS cases present with macrocephaly, distinctive facial skin lesions, and oral mucosal abnormalities (2), as well as developmental features such as autism spectrum disorders (3) . These characteristics often lead to early diagnosis and referral to genetic clinics. However, cases without prominent external features may remain undiagnosed until adulthood. While the detailed mechanisms are not fully elucidated, PTEN loss‑of‑function leads to carcinogenesis. CS/PHTS patients are at increased risk for characteristic tumors such as breast, endomet","cbCaiesfbDeXxrtC","https://ap.wps.com/l/cbCaiesfbDeXxrtC","pdf",1430147,"English","# Abstract\n## Background/Aim\n## Case Report\n## Conclusion\n# Introduction\n# Case Report","[{\"question\":\"What hereditary condition is highlighted in this case report, and what gene causes it?\",\"answer\":\"The report focuses on Cowden syndrome (CS)/PTEN hamartoma tumor syndrome (PHTS), caused by germline pathogenic variants in the PTEN gene.\"},{\"question\":\"What diagnosis was determined from the patient’s biopsy and genomic profiling?\",\"answer\":\"Liver biopsy indicated mixed acinar–endocrine carcinoma, and cancer genome profiling identified a germline PTEN variant (V201fs*1) along with pathogenic GNAS and TP53 variants, supporting a diagnosis of CS.\"},{\"question\":\"Which common pancreatic cancer alteration was absent, and how did the patient respond to treatment?\",\"answer\":\"KRAS mutations were absent. The patient showed extreme resistance to multiple chemotherapy regimens, including FOLFIRINOX and gemcitabine plus nab-paclitaxel, leading to rapid clinical decline.\"}]","Pancreatic Mixed Acinar-neuroendocrine Carcinoma in a Patient With a Germline PTEN Variant - A Case Report and Genomic Literature Review | PDF",1790175949,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34441e00176a709a672b361e539a84f9.webp",983,1301,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d67d28c97881e9133bad7dd21c05b3c.webp",982,1299,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27651850b52732cbfcc1ccccd1d89eac.webp",981,1298,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4cfe103a48a502a52f79e3dc69936606.webp",980,1297]